ea0029p807 | Endocrine tumours and neoplasia | ICEECE2012
Faggiano A.
, Ramundo V.
, Del Prete M.
, Marotta V.
, Marciello F.
, Camera L.
, Napolitano V.
, De L.
, Lombardi G.
, Colao A.
Somatostatin analogues (SSA) represent a recognized therapeutic option in patients affected with functioning neuroendocrine tumors (NET). In non-functioning NET, SSA are reported to induce tumor stabilization in most of cases and objective response in <5%. NET associated to Multiple Endocrine Neoplasia type 1 (MEN1) are inherited tumors, generally located in the duodeno-pancreatic trait, characterized by well differentiated histotype, high expression of somatostatin recept...